Last 30 days
Market attention
LSE · United Kingdom
CURE VanEck Genomics and Healthcare Innovators UCITS ETF
Current rank—Attention 0/100
Steady
Verified crowd view
What is your view on CURE?
Choose once. You can change your view later. Automated and suspicious votes are not included.
BuildingThe result appears after enough verified votes.